We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Autologous stem cell transplantation in EBV-positive post-renal transplant refractory multiple myeloma: A case report and literature review.
- Authors
Xie, Xiaobao; Lin, Yan; Cao, Yang; Dong, Weimin; Wu, Wei; Zhu, Yuandong; Liu, Deliang; Li, Haiqian; Li, Qing; Gu, Weiying
- Abstract
Renal transplant recipients exhibit an increased risk of developing plasma cell neoplasms (PCNs; comprising multiple myeloma and plasmacytoma); however, multiple myeloma manifesting with refractory extramedullary plasmacytomas associated with Epstein-Barr virus are markedly rare in these patients. In the present case report, an unusual case of refractory multiple myeloma with multiple extramedullary plasmacytoma (including liver, vertebrae, breast, muscle, skin and soft tissues) was presented. The patient exhibited mild bone marrow infiltration which was successfully treated with novel agents, including bortezomib and lenalidomide, followed by autologous stem cell transplantation (ASCT). In addition, the patient was a renal transplant recipient who achieved a partial clinical remission with controllable therapy-related toxicity effects. Therefore, the present case indicated that ASCT is an effective and safe salvage therapy for renal transplant recipients with secondary extramedullary plasmacytomas and who are resistant to traditional chemotherapy (bortezomib and lenalidomide). ASCT was well-tolerated in the renal transplant recipient.
- Subjects
MULTIPLE myeloma; KIDNEY transplantation; STEM cell transplantation; EPSTEIN-Barr virus; PLASMACYTOMA
- Publication
Oncology Letters, 2018, Vol 15, Issue 5, p7207
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2018.8237